Predictive Oncology plans to launch ChemoFx, a validated live cell drug response assay, in Europe, utilizing models developed for LabCorp.
1 report, 1 independent
Updated Aug 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Predictive Oncology plans to launch ChemoFx, a validated live cell drug response assay, in Europe, utilizing models developed for LabCorp.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Coverage
Newest first; wire copies grouped- GlobeNewswirePredictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update PITTSBURGH, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science-driven comp